No results were found for the filter!
Spike (XBB.1.16, Omicron Variant) (SARS-CoV-2)...
Item number: BPS-78784-1
The Spike (XBB.1.16, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentiviruses are replication incompetent, HIV-based lentiviral particles. They were produced with SARS-CoV-2 Spike (Genbank Accession #QHD43416.1 containing all the XBB.1.16 mutations, see below for details) as the envelope glycoprotein instead of the...
| Keywords: | 2, |
| Application: | SARS-CoV-2 Spike Omicron XBB.1.16 variant neutralizing antibody screening/titration |
| Species reactivity: | SARS-CoV-2 |
From 1,317.00€
*
Spike (XBB.1.16, Omicron Variant) (SARS-CoV-2)...
Item number: BPS-78785-1
The Spike (XBB.1.16 Omicron Variant) (SARS-CoV-2) Pseudotyped Lentiviruses are replication incompetent, HIV-based lentiviral particles. They were produced with SARS-CoV-2 Spike (Genbank Accession #QHD43416.1 containing all the Omicron XBB.1.16 mutations, see below for details) as the envelope glycoprotein instead of...
| Keywords: | 2, |
| Application: | SARS-CoV-2 Spike Omicron XBB.1.16 variant neutralizing antibody screening/titration |
| Species reactivity: | SARS-CoV-2 |
From 1,317.00€
*
Cas9 Lentivirus (Inducible Tet-On)
Item number: BPS-78794
Cas9 Lentiviruses (Inducible Tet-On) are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce most mammalian cells, including primary and non-dividing cells. These viruses transduce cells with the Streptococcus pyogenes Cas9 gene under a tight TRE...
| Keywords: | SpCas9, SpyCas9, SPy_1046, CRISPR-associated endonuclease Cas9/Csn1, |
| Application: | Tet-inducible Cas9 stable cell line generation (Geneticin selection), genetic engineering studies |
| Species reactivity: | mammalian |
1,180.00€
*
STAT6 Luciferase Reporter Lentivirus (STAT6 Signaling...
Item number: BPS-78799
The STAT6 Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce most mammalian cells, including primary and non-dividing cells. These viruses contain a firefly luciferase reporter driven by multiple copies of STAT6 (signal...
| Keywords: | STAT6, IL-4 Stat, Signal transducer and activator of transcription 6, |
| Application: | Activator/inhibitor screening (luciferase readout), stable cell line generation (puromycin selection) |
| Species reactivity: | human |
1,389.00€
*
Cas9 Inducible (Tet-On) iPS Cell Pool
Item number: BPS-78845
The Cas9 Inducible (Tet-On) iPS Cell Pool expresses the Cas9 (Streptococcus pyogenes CRISPR associated protein 9) gene under the control of a tight TRE tetracycline-inducible promoter, introduced into PBMC-derived human iPS cells via lentiviral transduction [Cas9 Lentivirus (inducible TET on), BPS Bioscience...
| Keywords: | iPSC, |
| Application: | Temporally controlled gene editing induction, sgRNA-edited iPS cell pool generation, screening |
| Species reactivity: | human |
11,345.00€
*
AAV-DJ Scrambled shRNA Control
Item number: BPS-78871
This AAV-DJ Scrambled shRNA (short-hairpin RNA) Control co-expresses a 29-mer scrambled shRNA sequence under the control of a U6 promoter, and Turbo GFP under the control of a CMV promoter to assess the efficacy of transduction.
| Application: | Negative control (gene-specific shRNA transduction via AAV vectors) |
803.00€
*
DLL3 CHO Cell Line
Item number: BPS-78882
CHO-K1 cells expressing human delta like canonical Notch ligand 3 (DLL3) gene (accession number NM_016941.3) under the control of the cytomegalovirus (CMV) promoter. This cell line was generated by lentiviral transduction followed by puromycin selection and limited dilution. Individual clones were screened based on...
| Keywords: | DLL3, Delta3, Delta-like protein 3, Drosophila Delta homolog 3, |
| Application: | Validation target cells, small molecule DLL3 targeting drug validation/characterization, CAR-T study |
| Species reactivity: | human |
9,308.00€
*
BCMA CRISPR/Cas9 Lentivirus (Integrating)
Item number: BPS-78893
The BCMA CRISPR/Ca9 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudo-typed lentiviral particles that are ready to transduce most mammalian cells, including primary and non-dividing cells. These viruses contain a CRISPR/Cas9 gene, driven by an EF1A promoter, and 5 sgRNA (single guide RNA) targeting...
| Keywords: | knockout, knock-out, KO, |
| Application: | BCMA knock-out/BMCA knock-out cell pool generation, stable BCMA knock-out cell line generation |
| Species reactivity: | human |
1,223.00€
*
BCMA CRISPR/Cas9 Lentivirus (Non-Integrating)
Item number: BPS-78894
The BCMA CRISPR/Cas9 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudo-typed lentiviral particles that are ready to transduce most mammalian cells, including primary and non-dividing cells. These viruses contain a CRISPR/Cas9 gene, driven by an EF1A promoter, and with 5 sgRNA (single guide RNA)...
| Keywords: | BCM, CD269, TNFRSF17, B-cell maturation protein, Tumor necrosis factor receptor superfamily member 17, |
| Application: | BCMA knock-out/BMCA knock-out cell pool generation, stable BCMA knock-out cell line generation |
| Species reactivity: | human |
1,223.00€
*
Frozen human plasma from whole human blood in K2EDTA -...
Item number: R-PLSSKF2EDT10-MSXX
Product Description: Frozen human plasma produced from fresh whole blood from a male donor collected in K2EDTA anticoagulant. Blood comes from a healthy donor aged between 18-66. Donors are screened and tested negative for HIV, Hepatitis B and C and Syphilis. The plasma is stored and shipped under frozen conditions....
| Host: | Human male |
| Species reactivity: | human |
From 66.00€
*
HeLa Whole Cell Lysate, 1.0 mg/ml by BCA assay, in 1X...
Item number: W09-000-364
| Application: | WB, Positive control |
204.00€
*
Fresh human peripheral blood buffy coat from sodium...
Item number: R-BUF1DA2CIT24-MSXX
Product Description: Fresh human peripheral blood buffy coat produced from fresh whole blood from a male donor collected in Vacutainers containing sodium citrate anticoagulant. The buffy coat is produced by centrifugation of 432 ml whole blood. Total final volume is typically 24 ml. Blood comes from a healthy donor...
| Host: | Human male |
| Species reactivity: | human |
From 167.00€
*